Everything about Dimethylarginine Dimethylaminohydrolase totally explained
Dimethylarginine dimethylaminohydrolase (
DDAH) is an
enzyme found in all
mammalian
cells. Two isoforms exist, DDAH I and DDAH II, with some differences in tissue distribution of the two isoforms). The enzyme degrades
methylarginines, specifically
asymmetric dimethylarginine (ADMA) and NG-monomethyl-L-arginine (MMA). The methylarginines ADMA and MMA inhibit the production of
nitric oxide synthase. Accordingly, DDAH is important in removing methylarginines, generated by protein degradation, from accumulating and inhibiting the generation of nitric oxide.
Inhibition of DDAH activity causes methylarginines to accumulate, blocking
nitric oxide(NO) synthesis and causing
vasoconstriction. An impairment of DDAH activity appears to be involved in the elevation of plasma ADMA, and impairment of vascular relaxation observed in humans with
cardiovascular disease or risk factors (such as
hypercholesterolemia,
diabetes mellitus, and
insulin resistance). The activity of DDAH is impaired by
oxidative stress, permitting ADMA to accumulate. A wide range of pathologic stimuli induce endothelial oxidative stress such as oxidized
LDL-cholesterol,
inflammatory cytokines,
hyperhomocysteinemia,
hyperglycemia and
infectious agents. Each of these insults attenuates DDAH activity
in vitro and
in vivo. The attenuation of DDAH allows ADMA to accumulate, and to block NO synthesis. The adverse effect of these stimuli can be reversed in vitro by
antioxidants, which preserve the activity of DDAH.
The sensitivity of DDAH to oxidative stress is conferred by a critical
sulfhydryl in the
active site of the enzyme that's required for the
metabolism of ADMA. This sulfhydryl can also be reversibly inhibited by NO in an elegant form of
negative feedback.
Homocysteine (a putative cardiovascular risk factor) mounts an oxidative attack on DDAH to form a mixed
disulfide, inactivating the enzyme. In this animal, the activity of DDAH is increased, and
plasma ADMA levels are reduced by 50%. The reduction in plasma ADMA is associated with a significant increase in NOS activity, as plasma and
urinary nitrate levels are doubled. The increase in NOS activity translates into a 15mmHg reduction in
systolic blood pressure in the transgenic mouse. This study provides evidence for the importance of DDAH activity and plasma ADMA levels in the regulation of NO synthesis. Subsequent studies have shown that DDAH transgenic animals also manifest improvements in
endothelial regeneration and
angiogenesis, and reduced vascular obstructive disease, in association with the reduced plasma levels of ADMA. These findings are consistent with evidence from a number of groups that nitric oxide plays a critical role in vascular regeneration. By contrast, elevations in ADMA impair angiogenesis. These insights into the role of DDAH in degrading endogenous inhibitors of NOS, and thereby maintaining vascular NO production, may have important implications in vascular health and therapy for cardiovascular disease.
Further Information
Get more info on 'Dimethylarginine Dimethylaminohydrolase'.
|
External Link Exchanges
Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:
<a href="http://dimethylarginine_dimethylaminohydrolase.totallyexplained.com">Dimethylarginine dimethylaminohydrolase Totally Explained</a>
Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned. |